搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 天
葛兰素史克在Zantac案件中达成22亿美元的和解协议
葛兰素史克公司周三表示,已与10家原告公司达成协议,这些公司占美国州法院针对该制药商的Zantac产品责任案件的93%,和解金额高达22亿美元。
6 天
葛兰素史克(GSK.US)同意支付22亿美元以解决约8万起胃灼热药物Zantac ...
智通财经获悉,葛兰素史克(GSK.US)周三宣布,该公司已同意支付高达22亿美元,以解决美国州法院提起的大多数诉讼,这些诉讼指控一种已停产的胃灼热药物Zantac会导致癌症。该公司说,与10家原告律师事务所达成的协议解决了约8万起案件,占美国全国州法 ...
7 天
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of ...
6 天
on MSN
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court ...
7 天
GSK将支付高达22亿美元解决Zantac诉讼案
领先的制药公司GSK plc (NYSE:GSK)今天宣布达成和解,以解决美国州法院大多数未决的Zantac(雷尼替丁)产品责任案件。该公司将支付高达22亿美元来解决约8万起案件,占针对该公司索赔的93%。此外,GSK原则上同意以7000万美元和解Valisure提起的qui tam诉讼。 这些和解并不意味着GSK承认任何责任,预计将在2025年上半年末前全面实施。GSK坚持认为,没有确凿的科学证 ...
7 天
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
5 天
美股异动丨葛兰素史克跌1.35% 同意支付22亿美元以解决胃灼热药物 ...
葛兰素史克(GSK.US)跌1.35%,报39.69美元。消息面上,葛兰素史克周三宣布,同意支付高达22亿美元,以解决美国州法院提起的大多数诉讼,这些诉讼指控一种已停产的胃灼热药物Zantac会导致癌症。该公司与10家原告律师事务所达成的协议解决了约 ...
新浪网
6 天
葛兰素史克(GSK.US)同意支付22亿美元以解决约8万起胃灼热药物Zantac ...
Zantac于1983年首次获得美国监管机构的批准,并于1988年成为世界上最畅销的药物,也是首批年销售额超过10亿美元的药物之一。这种药物在不同时期由 ...
6 天
on MSN
GSK settles vast majority of Zantac claims for $2.2 billion
The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn ...
7 天
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...
7 天
GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B
The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈